Last checked at 26 Aug 2008 10:41
26 August 2008
PROVEXIS PLC
("PROVEXIS" OR "THE COMPANY")
Result of Meeting
Provexis plc, the life-science business that discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologies, announces that further to its announcement of 1 August 2008, all of the resolutions proposed at the Extraordinary General Meeting held earlier today were duly passed.
It is expected that the 386,894,230 New Ordinary Shares of 0.1p each in the Company placed at 0.65p per share with institutional and other investors, and certain of the Company's Directors, will be admitted to AIM on Thursday 28 August 2008. Following Admission, the Company will have in issue 788,618,596 Ordinary Shares of 0.1p each.
Certain terms used in this announcement are defined and have the same meaning as in the Company's announcement of 1 August 2008.
ENQUIRIES
| Provexis plc | Tel. 01753 752 290 |
| Stephen Moon, CEO | |
| Ian Ford, FD | |
| Arbuthnot | Tel. 020 7012 2000 |
| Tom Griffiths | |
| Alasdair Younie |
END